Dynavax Technologies | Netto Inntekt



Net Income Endring Dato
AbbVie USD 1.29B 1.31B 2025-03
Adma Biologics USD 111.9M 75.99M 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Dynavax Technologies USD 7.05M 10.54M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
TG Therapeutics USD 23.33M 19.45M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Dynavax Technologies Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.